Prudential plc (PRU.L)
London, GB
Prudential plc, operating through its subsidiaries, specializes in providing life and health insurance, retirement solutions, and investment management services to individuals across Asia and Africa. Its comprehensive product range features health and protection policies, along with various savings options, such as participating, linked, and traditional products. The company additionally offers coverage for major critical illnesses like cancer, stroke, and heart attack, as well as specialized protection against tropical diseases including dengue, malaria, and measles. For both institutional and individual investors, Prudential plc actively manages assets using diverse strategies, encompassing equity, fixed income, multi-asset, quantitative, and alternative investments. Its offerings are distributed through an extensive network of agency sales forces, banking partners, and independent brokers. Established in 1848, the firm maintains its corporate headquarters in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.43% | -5.80% | -2.41% | -5.80% | -2.01% | -6.38% | +26.77% | +1.47% | -26.16% | -6.26% | +635.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 8 | 0 |
| Hold | 1 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+117.4% ★ Q4'25: +152.7% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%+85.7% ★ Q4'25: +377.3% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%+10.0% ★ Q4'25: +9.9% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+19.1% ★ Q4'25: +23.1% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+22.1% ★ Q4'25: +57.9% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%-5.2% ★ Q4'25: -6.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.11× Q4'25: 0.43× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 6 EPS Ana. |
Dec 2027 2 Rev. Ana. 6 EPS Ana. |
Dec 2028 2 Rev. Ana. 7 EPS Ana. |
Dec 2029 1 Rev. Ana. 2 EPS Ana. |
Dec 2030 1 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
26.94B
est.
|
29.27B
est.
|
29.85B
est.
|
33.90B
est: 31.17B (+8.8%)
|
41.13B
est: 28.90B (+42.3%)
|
35.03B
est: 31.45B (+11.4%)
|
32.87B
est: 34.43B (-4.5%)
|
-10.27B
est: 34.03B (-130.2%)
|
48.10B
est: 55.28B (-13.0%)
|
47.65B
est: 51.04B (-6.6%)
|
36.51B
est: 62.39B (-41.5%)
|
54.44B
est: 64.83B (-16.0%)
|
54.10B
est: 85.27B (-36.6%)
|
59.92B
est: 75.99B (-21.1%)
|
41.31B
est: 49.04B (-15.8%)
|
71.84B
est: 43.36B (+65.7%)
|
86.56B
est: 52.69B (+64.3%)
|
26.88B
est: 57.29B (-53.1%)
|
73.48B
est: 60.74B (+21.0%)
|
28.27B
est: 33.95B (-16.7%)
|
19.27B
est: 25.12B (-23.3%)
|
7.11B
est: 24.87B (-71.4%)
|
15.69B
est: 13.85B (+13.3%)
|
13.04B
est: 3.84B (+239.7%)
|
28.34B
est: 6.55B (+332.8%)
|
6.77B
3.69B – 9.85B
+3.4% YoY
|
7.25B
4.01B – 10.48B
+7.1% YoY
|
9.12B
5.01B – 13.22B
+25.8% YoY
|
80.91B
44.46B – 117.37B
+787.7% YoY
|
105.18B
57.79B – 152.57B
+30.0% YoY
|
| EBITDA |
1.11B
est.
|
-223.08M
est.
|
242.48M
est.
|
1.64B
est: 581.79M (+181.0%)
|
-208.00M
est: 1.39B (-115.0%)
|
-177.00M
est: 3.61B (-104.9%)
|
-168.00M
est: 3.99B (-104.2%)
|
-172.00M
est: 2.37B (-107.2%)
|
-209.00M
est: -1.78B (+88.3%)
|
-257.00M
est: 794.38M (-132.4%)
|
-286.00M
est: 2.29B (-112.5%)
|
3.40B
est: 2.71B (+25.5%)
|
2.39B
est: 5.20B (-54.1%)
|
3.50B
est: 2.15B (+62.8%)
|
3.63B
est: 3.78B (-4.0%)
|
3.57B
est: 5.03B (-28.9%)
|
4.40B
est: 4.34B (+1.3%)
|
3.08B
est: 5.14B (-40.1%)
|
2.20B
est: 3.97B (-44.6%)
|
2.73B
est: 800.46M (+240.5%)
|
2.43B
est: 980.77M (+148.1%)
|
-258.97M
est: 1.16B (-122.4%)
|
1.97B
est: 1.69B (+16.2%)
|
2.67B
est: 468.86M (+469.2%)
|
5.42B
est: 799.95M (+576.9%)
|
826.87M
450.56M – 1.20B
+3.4% YoY
|
885.51M
490.13M – 1.28B
+7.1% YoY
|
1.11B
611.94M – 1.62B
+25.8% YoY
|
9.89B
5.43B – 14.34B
+787.7% YoY
|
12.85B
7.06B – 18.64B
+30.0% YoY
|
| EBIT |
1.05B
est.
|
1.06B
est.
|
689.78M
est.
|
1.64B
est: 696.74M (+134.7%)
|
2.35B
est: 981.73M (+139.7%)
|
2.40B
est: 4.41B (-45.6%)
|
1.23B
est: 4.89B (-74.9%)
|
-1.90B
est: 2.56B (-174.3%)
|
1.77B
est: -835.12M (+312.3%)
|
2.33B
est: 1.40B (+66.5%)
|
2.21B
est: 3.22B (-31.4%)
|
3.40B
est: 3.54B (-4.2%)
|
2.39B
est: 6.36B (-62.4%)
|
3.50B
est: 2.61B (+34.1%)
|
3.63B
est: 3.90B (-6.7%)
|
3.57B
est: 5.41B (-34.0%)
|
4.40B
est: 5.05B (-13.1%)
|
3.08B
est: 6.43B (-52.2%)
|
2.20B
est: 3.35B (-34.3%)
|
2.73B
est: 2.58B (+5.6%)
|
2.43B
est: 3.16B (-23.1%)
|
-258.97M
est: 3.73B (-106.9%)
|
1.97B
est: 1.69B (+16.2%)
|
2.67B
est: 468.86M (+469.2%)
|
5.42B
est: 799.95M (+576.9%)
|
826.87M
450.56M – 1.20B
+3.4% YoY
|
885.51M
490.13M – 1.28B
+7.1% YoY
|
1.11B
611.94M – 1.62B
+25.8% YoY
|
9.89B
5.43B – 14.34B
+787.7% YoY
|
12.85B
7.06B – 18.64B
+30.0% YoY
|
| Net Income |
780.42M
est.
|
633.42M
est.
|
676.22M
est.
|
491.00M
est: 367.82M (+33.5%)
|
748.00M
est: 762.58M (-1.9%)
|
874.00M
est: 1.40B (-37.6%)
|
947.00M
est: 1.87B (-49.5%)
|
-396.00M
est: 1.96B (-120.2%)
|
676.00M
est: -1.14B (+159.1%)
|
1.43B
est: 1.00B (+42.6%)
|
1.49B
est: 2.70B (-44.9%)
|
2.16B
est: 2.40B (-9.9%)
|
1.35B
est: 4.52B (-70.2%)
|
2.22B
est: 1.96B (+13.3%)
|
2.58B
est: 3.25B (-20.8%)
|
1.92B
est: 4.27B (-55.0%)
|
2.39B
est: 3.96B (-39.6%)
|
3.01B
est: 4.49B (-32.9%)
|
613.76M
est: 3.66B (-83.2%)
|
1.65B
est: 990.14M (+66.8%)
|
-1.48B
est: 1.21B (-222.4%)
|
-817.52M
est: 4.37B (-118.7%)
|
1.37B
est: 1.11B (+23.3%)
|
1.79B
est: 2.01B (-10.9%)
|
4.06B
est: 2.63B (+54.4%)
|
3.20B
3.01B – 3.39B
+21.6% YoY
|
3.59B
2.86B – 4.32B
+12.2% YoY
|
4.17B
3.86B – 4.49B
+16.2% YoY
|
4.42B
1.83B – 7.00B
+5.8% YoY
|
5.09B
2.11B – 8.07B
+15.2% YoY
|
| SGA |
4.06B
est.
|
4.41B
est.
|
4.50B
est.
|
3.60B
est: 4.70B (-23.3%)
|
3.60B
est: 4.35B (-17.4%)
|
2.81B
est: 7.75B (-63.8%)
|
3.72B
est: 8.59B (-56.7%)
|
1.19B
est: 6.71B (-82.2%)
|
3.47B
est: 3.68B (-5.8%)
|
3.41B
est: 5.25B (-35.0%)
|
2.88B
est: 6.61B (-56.4%)
|
3.14B
est: 5.68B (-44.7%)
|
3.79B
est: 7.67B (-50.5%)
|
4.33B
est: 6.25B (-30.8%)
|
—
est: 6.59B (-100.0%)
|
—
est: 7.86B (-100.0%)
|
—
est: 11.38B (-100.0%)
|
—
est: 11.68B (-100.0%)
|
—
est: 3.53B (-100.0%)
|
—
est: 6.35B (-100.0%)
|
—
est: 7.78B (-100.0%)
|
—
est: 9.17B (-100.0%)
|
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
0.60
est.
|
0.56
est.
|
0.53
est.
|
0.24
est: 0.66 (-63.7%)
|
0.32
est: 0.76 (-57.9%)
|
0.36
est: 1.10 (-67.3%)
|
0.39
est: 1.44 (-72.8%)
|
-0.16
est: 1.32 (-112.1%)
|
0.27
est: 1.88 (-85.7%)
|
0.57
est: 1.26 (-54.8%)
|
0.59
est: 1.45 (-59.2%)
|
0.85
est: 1.71 (-50.2%)
|
0.33
est: 2.16 (-84.7%)
|
0.54
est: 2.45 (-77.9%)
|
0.68
est: 1.35 (-49.5%)
|
0.61
est: 1.22 (-50.0%)
|
0.70
est: 1.57 (-55.4%)
|
0.91
est: 1.60 (-43.1%)
|
0.23
est: 1.56 (-85.3%)
|
0.82
est: 1.62 (-49.3%)
|
-0.77
est: 1.02 (-175.3%)
|
-0.37
est: 0.80 (-146.4%)
|
0.62
est: 0.40 (+53.1%)
|
0.84
est: 0.78 (+7.9%)
|
1.57
est: 1.02 (+53.6%)
|
1.22
1.17 – 1.31
+19.7% YoY
|
1.44
1.11 – 1.68
+17.7% YoY
|
1.59
1.49 – 1.74
+10.1% YoY
|
1.71
0.71 – 2.71
+8.0% YoY
|
1.97
0.82 – 3.13
+15.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 3/5 | 1/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anil Wadhwani | Chief Executive Officer & Executive Director | 4M | male |
| Anette Bronder | Chief Technology & Operations Officer | — | female |
| Avnish Kalra | Chief Risk & Compliance Officer | — | male |
| Benjamin James Bulmer | Chief Financial Officer | — | male |
| Catherine Chia | Chief Human Resources Officer | — | female |
| Ciaran Mulligan | Head of Manager Oversight for Portfolio Management Group | — | — |
| Patrick Bowes | Head of Investor Relations | — | male |
| Rebecca Wyatt | Chief of Financial & Capital Reporting | — | — |
| Allen Thai | Chief Representative of Myanmar Office | — | male |
| Thean Oon Tan | Regional CEO of Singapore, Thailand, Vietnam & Partnership Distribution | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PRU.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
